SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-17-045306
Filing Date
2017-07-17
Accepted
2017-07-17 16:22:57
Documents
7
Period of Report
2017-07-17

Document Format Files

Seq Description Document Type Size
1 6-K a17-17995_16k.htm 6-K 35832
2 EX-10.1 a17-17995_1ex10d1.htm EX-10.1 1667558
3 EX-10.2 a17-17995_1ex10d2.htm EX-10.2 502134
4 EX-10.3 a17-17995_1ex10d3.htm EX-10.3 178882
5 EX-10.4 a17-17995_1ex10d4.htm EX-10.4 143688
6 EX-99.1 a17-17995_1ex99d1.htm EX-99.1 15628
7 GRAPHIC g179951mmi001.jpg GRAPHIC 3085
  Complete submission text file 0001104659-17-045306.txt   2549179
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 17967754
SIC: 2834 Pharmaceutical Preparations